A new Form 4 filing shows Colin Walsh, a director at Attovia Therapeutics, Inc. (ATTO), purchased 500,000 shares of company stock on the open market on August 6, 2026. The purchase price was $17.00 per share, bringing the total outlay to $8,500,000.00. Following the transaction, Walsh’s indirect holdings — held via a trust or entity — stand at 3,020,632 shares.
Because the shares were bought on the open market rather than acquired through options or other compensation arrangements, the filing represents a direct, out-of-pocket bet by the director, priced at the same $17.00 level the market was trading at the day of purchase.
Part of a Broader Buying Pattern
Walsh’s purchase is not an isolated event. Our tracking shows two open-market purchases of Attovia Therapeutics stock between August 5 and August 6, 2026, with a combined value of $10,285,000. That two insiders were willing to commit eight-figure sums to the stock within a 48-hour window is the more significant part of this story than any single filing on its own. We have classified this activity as a cluster buy, a label reserved for situations where multiple insiders purchase shares in close proximity to one another.
Academic research on insider trading disclosures has found that clustered buying — several insiders purchasing around the same time — tends to correlate with above-average stock performance in the periods that follow, more so than isolated purchases by a single insider. That is a statistical pattern observed across large datasets of filings, not a prediction or endorsement of any particular outcome for Attovia Therapeutics.
This week’s activity at ATTO has already generated separate coverage on this site. Readers can find more detail on another recent purchase in our article, ATTO: venBio Buys $6.5M in Attovia Therapeutics Stock, which outlines a different insider’s stake-building activity around the same period.
Taken together, the filings paint a picture of concentrated insider interest in Attovia Therapeutics in early August 2026. Whether this reflects internal confidence tied to specific company developments is not disclosed in the Form 4 filings themselves, which report only the mechanics of the transactions — shares, price, date, and resulting ownership — and not the insiders’ underlying reasoning.
→ See all ATTO coverage on WhoIsBuyingNow
Source: original SEC Form 4 filing.